Use of genetic data to guide therapy in arterial disease.

Abstract excerpt

There is considerable interindividual variation in the response to antiplatelet and anticoagulant therapies. It has been proposed that this variability in drug response may be attributable to genetic variants. Thus, pharmacogenetics may help to accurately predict response to cardiovascular disease (CVD) therapies in order to maximize drug efficacy, minimize drug toxicity, and to tailor personalized care for these...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Resistance
• Share to Anticoagulants
• Share to Biotransformation